Literature DB >> 34813029

Intravenous Milrinone for Cerebral Vasospasm: Here Comes the Sun?

Karim Lakhal1,2, Vincent Robert-Edan3,4, Pierre-André Rodie-Talbere3,4, Xavier Ambrosi3,4, Marion Fresco3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34813029     DOI： 10.1007/s12028-021-01392-0

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  2 in total

1.  Intravenous Milrinone for Cerebral Vasospasm: Here Comes the Sun?

Authors:  Karim Lakhal; Vincent Robert-Edan; Pierre-André Rodie-Talbere; Xavier Ambrosi; Marion Fresco
Journal:  Neurocrit Care       Date:  2021-11-23       Impact factor: 3.210

2.  Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice.

Authors:  Lionel J Velly; Federico Bilotta; Neus Fàbregas; Martin Soehle; Nicolas J Bruder; Michael H Nathanson
Journal:  Eur J Anaesthesiol       Date:  2015-03       Impact factor: 4.330
  2 in total
  5 in total

1.  Role of Induced Hypertension and Intravenous Milrinone After Aneurysmal Subarachnoid Hemorrhage: Is it Time to Shift the Paradigm?

Authors:  Yasser B Abulhasan; Johanna Ortiz Jimenez; Jeanne Teitelbaum; Mark R Angle
Journal:  Neurocrit Care       Date:  2021-11-03       Impact factor: 3.210

2.  Intravenous Milrinone for Cerebral Vasospasm: Here Comes the Sun?

Authors:  Karim Lakhal; Vincent Robert-Edan; Pierre-André Rodie-Talbere; Xavier Ambrosi; Marion Fresco
Journal:  Neurocrit Care       Date:  2021-11-23       Impact factor: 3.210

3.  Intravenous Milrinone for Cerebral Vasospasm in Subarachnoid Hemorrhage.

Authors:  Charu Mahajan; Ratnesh Kumar Shukla; Indu Kapoor; Hemanshu Prabhakar
Journal:  Neurocrit Care       Date:  2022-02       Impact factor: 3.210

4.  Induced Hypertension or Intravenous Milrinone for Cerebral Vasospasm: Why Choose?

Authors:  Karim Lakhal; Antoine Hivert; Bertrand Rozec; Julien Cadiet
Journal:  Neurocrit Care       Date:  2021-11-01       Impact factor: 3.210

5.  Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Hans-Jakob Steiger; Rolf Ensner; Lukas Andereggen; Luca Remonda; Jatta Berberat; Serge Marbacher
Journal:  Acta Neurochir (Wien)       Date:  2022-02-09       Impact factor: 2.816
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.